Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14
PRO-nCOV-3001
Phase 3 mab completed
Quick answer
Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14 for Covid19 is a Phase 3 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Covid19
- Phase
- Phase 3
- Modality
- mab
- Status
- completed